Skip to main content
OpenTrials

Clinical trial condition

DM1

Explore clinical trials studying DM1. Study availability and eligibility vary by location and protocol.

10 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

DM1 trial results

Recruiting

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

NCT07486934

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, Genetic Diseases, Inborn, +18 more
Locations
  • UCSD - Altman Clinical and Translational Research Institute La Jolla, California, United States
  • Rare Disease Research, LLC Atlanta, Georgia, United States
  • IU Health Neuroscience Center Indianapolis, Indiana, United States
  • Roy Blunt NextGen Precision Health Institute Columbia, Missouri, United States
View all 21 locations
View Trial Details
Recruiting

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

NCT03981575

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, Genetic Diseases, Inborn, +11 more
Locations
  • University of California, San Diego La Jolla, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of Colorado - Denver Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View all 17 locations
View Trial Details
Recruiting

The Spanish National Registry for Myotonic Dystrophy Type 1

NCT07385443

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, Genetic Diseases, Inborn, +14 more
Locations
  • Hospitals within the DM1 network Multiple Locations, Andalusia, Spain
  • Hospitals within the DM1 network Multiple Locations, Basque Country, Spain
  • Hospitals within the DM1 network Multiple Locations, Canary Islands, Spain
  • Hospitals within the DM1 network Multiple Locations, Cantabria, Spain
View Trial Details
Enrolling by Invitation

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

NCT07008469

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, Genetic Diseases, Inborn, +19 more
Locations
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • University of Colorado Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View all 35 locations
View Trial Details
Completed

Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients

NCT05027269

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, Dystrophy Myotonic, +15 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • University of Colorado Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View Trial Details
Completed

Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients

NCT05479981

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, Genetic Diseases, Inborn, +11 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • University of Colorado Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View Trial Details
Active, Not Recruiting

Global Study of Del-desiran for the Treatment of DM1

NCT06411288

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, Dystrophy Myotonic, +21 more
Locations
  • Stanford University Stanford, California, United States
  • University of Colorado Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
  • University Research Center of South Florida Tampa, Florida, United States
View all 34 locations
View Trial Details

Related conditions